BiomX Inc. (PHGE) Dividend History

BiomX Inc. is a biotechnology company focused on the development of microbiome-based therapies for various diseases. Utilizing its proprietary platform, it identifies and engineers beneficial bacteria to address conditions related to inflammation, metabolic disorders, and other chronic illnesses. The company aims to harness the microbiome's potential to offer novel, personalized treatment options.

Dividend History

BiomX Inc. currently does not pay dividends

Company News

  • BiomX initiated a Phase 2b clinical trial for BX004, a phage therapy targeting Pseudomonas aeruginosa infections in cystic fibrosis patients. The trial involves 60 patients and aims to evaluate bacterial reduction, lung function improvements, and quality of life metrics, with topline results expected in Q1 2026.

    GlobeNewswire Inc.
  • BiomX (PHGE) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

    Zacks Investment Research
  • Here's what you need to know about trading penny stocks with $1,000 The post Trading Penny Stocks With $1,000, Top Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: RVSN
  • Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS guidance below estimates. Patterson posted adjusted earnings of 50 cents per share, missing market estimates of 58 cents per share. The company’s quarterly sales came in at $1.65 billion versus expectations of $1.70 billion. Patterson shares declined 14% to $27.01 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares jumped 135.2% to $10.53 after the company received first ever FDA 510(k) clearance for oral device treatment of severe obstructive sleep apnea. China Pharma Holdings, Inc. (NYSE: CPHI) climbed 86.7% to $0.1861. China Pharma reported completion of third party testing of dry eye disease therapeutic device. Envoy Medical, Inc. (NASDAQ: COCH) shares jumped 55.3% to $2.75. Envoy Medical, last week, reported a profit for the third quarter. Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 49.4% to $0.2841. Avenue Therapeutics recently posted a profit for the third quarter. Biomea Fusion, Inc. (NASDAQ: BMEA) shares jumped 40.1% to $13.93. Yoshiharu Global Co. (NASDAQ: YOSH) shares gained 33.4% to $6.39 after gaining over 22% on Tuesday. 10X Capital Venture Acquisition Corp. II (NASDAQ: VCXA) surged 30.3% to $10.61. Rover Group, Inc. (NASDAQ: ROVR) gained 28.4% to $10.93 after the company announced it agreed to be acquired by Blackstone in a $2.3 billion transaction. Fluence Energy, Inc. (NASDAQ: FLNC) shares jumped 28% to $25.95 after reporting fourth-quarter results. Fluence Energy also initiated FY24 revenue guidance of $2.7 billion to $3.3 billion. Ault Alliance, Inc. (NYSE: AULT) shares gained 25.6% to $0.1020. Ault Alliance announced its intention to commence an exchange offer to acquire shares of its ...

    Benzinga
  • The body's so-called germ squad in the gut can be tweaked, treating diseases including autism and Parkinson's disease.

    MarketWatch
    Featured Companies: JNJ MCRB PFE SYBX
Page data last updated 07/23/2025 16:09:59 UTC